ANIKA THERAPEUTICS INC. - COMMON STOCK

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

30 May 2023 16:05:37 By Nasdaq GlobeNewswire

Anika Reports First Quarter 2023 Financial Results

09 May 2023 16:05:59 By Nasdaq GlobeNewswire

Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023

19 Apr 2023 08:30:34 By Nasdaq GlobeNewswire

Anika Enters Into Cooperation Agreement with Caligan Partners

13 Apr 2023 17:00:25 By Nasdaq GlobeNewswire

Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference

12 Apr 2023 09:00:46 By Nasdaq GlobeNewswire

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

03 Apr 2023 09:00:52 By Nasdaq GlobeNewswire

Anika Files Preliminary Proxy Statement

27 Mar 2023 08:55:17 By Nasdaq GlobeNewswire

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

15 Mar 2023 16:01:26 By Nasdaq GlobeNewswire

Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting

08 Mar 2023 10:00:26 By Nasdaq GlobeNewswire

Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results

06 Mar 2023 16:05:08 By Nasdaq GlobeNewswire

Anika to Participate in the Canaccord Genuity Musculoskeletal Conference

28 Feb 2023 09:00:29 By Nasdaq GlobeNewswire

Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023

21 Feb 2023 10:30:01 By Nasdaq GlobeNewswire

Anika Issues Statement

21 Feb 2023 10:00:38 By Nasdaq GlobeNewswire

Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

13 Feb 2023 08:30:13 By Nasdaq GlobeNewswire

Anika Reports Third Quarter Fiscal 2022 Financial Results

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

01 Nov 2022 08:00:32 By Nasdaq GlobeNewswire

Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

25 Oct 2022 09:25:20 By Nasdaq GlobeNewswire

Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release

12 Sep 2022 16:01:49 By Nasdaq GlobeNewswire

Anika Reports Second Quarter Fiscal 2022 Financial Results

03 Aug 2022 16:05:21 By Nasdaq GlobeNewswire

Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine

27 Jul 2022 09:15:31 By Nasdaq GlobeNewswire